Breast cancer aromatase expression evaluated by the novel antibody 677: Correlations to intra-tumor estrogen levels and hormone receptor status

Journal of Steroid Biochemistry and Molecular Biology

Volumn 118, Issue 4-5, 2010, Pages 237-241

  Geisler, Jürgen ^a,b   Suzuki, Takashi ^c   Helle, Hildegunn ^a   Miki, Yasuhiro ^c   Nagasaki, Shuji ^c   Duong, Nhat K ^a   Ekse, Dagfinn ^a   Aas, Turid ^b   Evans, Dean B ^d   Lønning, Per E ^a,b   Sasano, Hironobu ^c  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Aromatase antibody 677; Breast cancer; Estradiol; Tissue estrogens

Indexed keywords

AROMATASE; ENZYME ANTIBODY; ESTRADIOL; ESTROGEN RECEPTOR; ESTRONE; ESTRONE SULFATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 677; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; ANTIBODY; ESTROGEN;

BREAST CANCER; CANCER PATIENT; CANCER TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MASTECTOMY; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; TISSUE LEVEL; TISSUE SECTION; ARTICLE; BREAST TUMOR; CARCINOMA; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY; POSTMENOPAUSE;

ANTIBODIES; AROMATASE; BREAST NEOPLASMS; CARCINOMA; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; POSTMENOPAUSE; RECEPTORS, ESTROGEN;

EID: 77950359344     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.10.010     Document Type: Conference Paper

References (26)

1. T. Key, P. Appleby, I. Barnes, G. Reeves, Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies, J. Natl. Cancer Inst. 94 (8) (2002) 606-616.
2. J. Geisler, P.E. Lonning, Aromatase inhibitors as adjuvant treatment of breast cancer, Crit. Rev. Oncol. Hematol. 57 (1) (2006) 53-61.
3. P.E. Lonning, M. Dowsett, T.J. Powles, Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer, J. Steroid Biochem. 35 (3-4) (1990) 355-366.
4. M.A. Blankenstein, I. Maitimu-Smeele, G.H. Donker, J. Daroszewski, A. Milewicz, J.H. Thijssen, On the significance of in situ production of oestrogens in human breast cancer tissue, J. Steroid Biochem. Mol. Biol. 41 (3-8) (1992) 891-896.
5. A.A. van Landeghem, J. Poortman, M. Nabuurs, J.H. Thijssen, Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue, Cancer Res. 45 (6) (1985) 2900-2906. (Pubitemid 15232767)
6. R.C. Bonney, M.J. Reed, K. Davidson, P.A. Beranek, V.H. James, The relationship between 17 beta-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue, Clin. Endocrinol. (Oxf.) 19 (6) (1983) 727-739.
7. G.S. Chetrite, J. Cortes-Prieto, J.C. Philippe, F. Wright, J.R. Pasqualini, Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues, J. Steroid Biochem. Mol. Biol. 72 (1-2) (2000) 23-27.
8. P.C de Jong, J. van de Ven, H.W. Nortier, I. Maitimu-Smeele, T.H. Donker, J.H. Thijssen, P.H. Slee, R.A. Blankenstein, Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole, Cancer Res. 57 (11) (1997) 2109-2111.
9. M.J. Reed, G.W. Aherne, M.W. Ghilchik, S. Patel, J. Chakraborty, Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues, Int. J. Cancer 49 (4) (1991) 562-565.
10. C. Recchione, E. Venturelli, A. Manzari, A. Cavalleri, A. Martinetti, G. Secreto, Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues, J. Steroid Biochem. Mol. Biol. 52 (6) (1995) 541-546.
11. W.R Miller, M. Stuart, T. Sahmoud, J.M. Dixon, Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer, Br. J. Cancer 87 (9) (2002) 950-955.
12. J.S. O'Neill, R.A. Elton, W.R. Miller, Aromatase activity in adipose tissue from breast quadrants: a link with tumour site, Br. Med. J. (Clin. Res. Ed.) 296 (6624) (1988) 741-743.
13. W.R. Miller, J.M. Dixon, Antiaromatase agents: preclinical data and neoadjuvant therapy, Clin. Breast Cancer 1 (Suppl. 1) (2000) S9-S14.
14. S. Masamura, S.J. Santner, P. Gimotty, J. George, R.J. Santen, Mechanism for maintenance of high breast tumor estradiol concentrations in the absence of ovarian function: role of very high affinity tissue uptake, Breast Cancer Res. Treat. 42 (3) (1997) 215-226.
15. P.E. Lønning, H. Helle, N.K. Duong, D. Ekse, T. Aas, J. Geisler, Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status, J. Steroid Biochem. Mol. Biol. 117 (2009) 31-41.
16. J.R. Pasqualini, G. Chetrite, C. Blacker, M.C. Feinstein, L. Delalonde, M. Talbi, C. Maloche, Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients, J. Clin. Endocrinol. Metab. 81 (4) (1996) 1460-1464.
17. J.H Thijssen, M.A. Blankenstein, G.H. Donker, J. Daroszewski, Endogenous steroid hormones and local aromatase activity in the breast, J. Steroid Biochem. Mol. Biol. 39 (5B) (1991) 799-804.
18. J. Geisler, S. Detre, H. Berntsen, L. Ottestad, B. Lindtjorn, M. Dowsett, P. Einstein Lonning, Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer, Clin. Cancer Res. 7 (5) (2001) 1230-1236.
19. J. Geisler, H. Helle, D. Ekse, N.K. Duong, D.B. Evans, Y. Nordbo, T. Aas, P.E. Lonning, Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels, Clin. Cancer Res. 14 (19) (2008) 6330-6335.
20. H. Sasano, D.P. Edwards, T.J. Anderson, S.G. Silverberg, D.B. Evans, R.J. Santen, P. Ramage, E.R. Simpson, A.S. Bhatnagar, W.R. Miller, Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report, J. Steroid Biochem. Mol. Biol. 86 (3-5) (2003) 239-244.
21. H. Sasano, T.J. Anderson, S.G. Silverberg, R.J. Santen, M. Conway, D.P. Edwards, A. Krause, A.S. Bhatnagar, D.B. Evans, W.R. Miller, The validation of new aromatase monoclonal antibodies for immunohistochemistry-A correlation with biochemical activities in 46 cases of breast cancer, J. Steroid Biochem.Mol. Biol. 95 (1-5) (2005) 35-39.
22. J. Geisler, H. Berntsen, P.E. Lonning, A novel HPLC-RIA method for the simultaneous detection of estrone, estradiol and estrone sulphate levels in breast cancer tissue, J. Steroid Biochem. Mol. Biol. 72 (5) (2000) 259-264.
23. J Geisler, D. Ekse, H. Helle, N.K. Duong, P.E. Lonning, An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples, J. Steroid Biochem. Mol. Biol. 109 (1-2) (2008) 90-95.
24. A.H. Brodie, D. Jelovac, B. Long, The intratumoral aromatase model: studies with aromatase inhibitors and antiestrogens, J. Steroid Biochem. Mol. Biol. 86 (3-5) (2003) 283-288. (Pubitemid 37412566)
25. W.R. Miller, T.J. Anderson, W.J. Jack, Relationship between tumour aromatase activity, tumour characteristics and response to therapy, J. Steroid Biochem. Mol. Biol. 37 (6) (1990) 1055-1059.
26. H Sasano, N. Harada, Intratumoral aromatase in human breast, endometrial, and ovarian malignancies, Endocr. Rev. 19 (5) (1998) 593-607.